Data source? Health Vision (Medical Edition) June 6, 2065 438+02
Clinical source? Liaoning province diabetes treatment center
Clinical data were selected from patients with type 2 diabetes who visited the outpatient department of Liaoning Diabetes Treatment Center from March 200414 to July 2005 10. Selection criteria: ①38-55 years old patients with type 2 diabetes, male 16, female 20; ② Hyperlipidemia; ③ Continue to take the original medicine; ④ Patients who have not received insulin therapy; ⑤ Normal liver and kidney function, no cardiovascular and cerebrovascular diseases; ⑤ There is no contraindication to take this medicine.
Methods All patients were continuously supplemented with exogenous for 90 days. Liver and kidney function, cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein, fasting blood glucose, glycosylated hemoglobin and body mass index were measured before taking the medicine, and all indexes were reviewed for statistical analysis 90 days later.
Data analysis showed that after 90 days of exogenous SOD90 supplementation, ① fasting blood glucose, glycosylated hemoglobin and low density lipoprotein decreased significantly; ② Triglycerides decreased obviously; ③ It also has a certain effect on lowering cholesterol and increasing high density lipoprotein; ④ The body mass index of most overweight patients has a downward trend; ⑤ No other adverse reactions occurred in all patients, and the heart, liver and kidney functions were not affected. Clinical experiments have proved that exogenous SOD supplementation can significantly reduce blood sugar and blood lipid glycosylated hemoglobin in diabetic patients. It provides a good treatment for diabetic hyperlipidemia patients.
Retired cadre Huang Moxiang, female, 6 1 year-old, has many years of diabetes history. After supplementing exogenous SOD 1 1 day, the glycemic index dropped from 29.94 to 20.